Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parkinson's Disease

  Free Subscription


27.05.2019

1 Ann Intern Med
1 BMC Neurosci
2 J Neural Transm (Vienna)
1 J Neurochem
1 Mov Disord
3 Neurology
2 Neurosci Lett
1 Neuroscience


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Intern Med

  1. FRIEDMAN JH
    Early- vs late-start levodopa relieved symptoms but did not affect disease progression in Parkinson disease.
    Ann Intern Med. 2019;170:JC56.
    PubMed     Text format    


    BMC Neurosci

  2. CHEN Q, Chen Y, Zhang Y, Wang F, et al
    Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    BMC Neurosci. 2019;20:23.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  3. TESHUVA I, Hillel I, Gazit E, Giladi N, et al
    Using wearables to assess bradykinesia and rigidity in patients with Parkinson's disease: a focused, narrative review of the literature.
    J Neural Transm (Vienna). 2019 May 22. pii: 10.1007/s00702-019-02017.
    PubMed     Text format     Abstract available

  4. PAK K, Kim H, Seok JW, Lee MJ, et al
    Prediction of future weight change with dopamine transporter in patients with Parkinson's disease.
    J Neural Transm (Vienna). 2019 May 17. pii: 10.1007/s00702-019-02016.
    PubMed     Text format     Abstract available


    J Neurochem

  5. HUANG W, Xu Y, Zhang Y, Zhang P, et al
    Metabolomics-driven identification of adenosine deaminase as therapeutic target in a mouse model of Parkinson's disease.
    J Neurochem. 2019 May 23. doi: 10.1111/jnc.14774.
    PubMed     Text format     Abstract available


    Mov Disord

  6. SMYTH N, Skender E, David FJ, Munoz MJ, et al
    Endurance exercise reduces cortisol in Parkinson's disease with mild cognitive impairment.
    Mov Disord. 2019 May 20. doi: 10.1002/mds.27719.
    PubMed     Text format    


    Neurology

  7. GIANNINI G, Francois M, Lhommee E, Polosan M, et al
    Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease.
    Neurology. 2019 May 17. pii: WNL.0000000000007665.
    PubMed     Text format     Abstract available

  8. HUANG MH, Cheng CM, Huang KL, Hsu JW, et al
    Bipolar disorder and risk of Parkinson disease: A nationwide longitudinal study.
    Neurology. 2019 May 22. pii: WNL.0000000000007649.
    PubMed     Text format     Abstract available

  9. PONTONE GM, Koch G
    An association between bipolar disorder and Parkinson disease: When mood makes you move.
    Neurology. 2019 May 22. pii: WNL.0000000000007641.
    PubMed     Text format    


    Neurosci Lett

  10. DEL FABBRO L, Rossito Goes A, Jesse CR, de Gomes MG, et al
    Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson's disease.
    Neurosci Lett. 2019 May 20. pii: S0304-3940(19)30354.
    PubMed     Text format     Abstract available

  11. ZHENG J, Zang Q, Hu F, Wei H, et al
    Alpha-synuclein gene polymorphism affects risk of dementia in Han Chinese with Parkinson's disease.
    Neurosci Lett. 2019;706:146-150.
    PubMed     Text format     Abstract available


    Neuroscience

  12. SI X, Tian J, Chen Y, Yan Y, et al
    Central nervous system-derived exosomal alpha-synuclein in serum may be a biomarker in Parkinson's disease.
    Neuroscience. 2019 May 15. pii: S0306-4522(19)30331.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: